Development of Antimicrobial Biomaterials and Natural Alternatives against Biofilms and Implant-Related Infections
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "The Global Need for Effective Antibiotics".
Deadline for manuscript submissions: closed (15 September 2021) | Viewed by 50730
Special Issue Editors
Interests: biofilm-related infections; smart antibiotics; antibiotic-boosting substances; carcinogenesis and biofilms; holistic management of implant-infections
Special Issues, Collections and Topics in MDPI journals
Interests: biomedical engineering; biomaterials; polimers; local delivery systems
Special Issues, Collections and Topics in MDPI journals
Interests: dental medicine; bone cements; endodontics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Implantable medical devices, such as prosthetics, catheters, and several other devices, have revolutionized medicine, but they increase the risk of infection. Indeed, implant infection is one of the most frequent and severe complications associated with the use of biomaterials. Implant infections count as nosocomial infections, being a major cause of death and increased morbidity among hospitalized patients. Those infections are difficult to treat, often requiring surgical implant replacement. The mortality rates for periprosthetic joint infections are equivalent to the rates for breast cancer and melanoma. The most commonly cultured microorganisms in implant infections are Coagulase-Negative Staphylococci (CoNS; primarily S. epidermidis), followed by S. aureus and mixed flora. In previous decades, commercially available antibiotics lost their ability to fight against CoNS and several other microorganisms. CoNS of both animal and human origins represent an important reservoir of genetic elements that lead to resistance not only to beta-lactam antibiotics but also to other antibiotic classes. One additional mechanism contributing to this phenomenon and negatively affecting the antimicrobial susceptibility of CoNS is the potential of these bacteria to produce biofilms. The presence of biofilm results in antibiotic tolerance by bacteria because many of them cannot sufficiently penetrate through biofilms. There is an urgent need to investigate alternatives to antibiotic substances. Local antimicrobial therapies can contribute to better outcomes during infection treatments. The investigation of biomaterials able to deliver antibiotics, natural antimicrobial substances or antibiotic-boosting substances is of great interest.
This Special Issue seeks manuscript submissions that further investigate such substances in association with biomaterials for use in all areas of implantology. Submissions on local delivery systems, smart implants associated with antibiotic boosting substances, natural antimicrobials, and new antimicrobial substances are especially encouraged.
Prof. Dr. Débora C. Coraça-Huber
Prof. Dr. Eliana Aparecida de Rezende Duek
Prof. Dr. Marina Angélica Marciano da Silva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Biofilms
- Implant infections
- Antimicrobials
- Biomedical engineering
- Biomaterials
- Bolymers
- Local delivery systems
- Dental medicine
- Bone cements
- Endodontics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.